Levels of evidence and study designs: A brief introduction to dermato-epidemiologic research methodology

被引:10
作者
Chen, Yen-Ning [1 ,2 ]
Chi, Ching-Chi [2 ,3 ,4 ]
机构
[1] Chang Gung Mem Hosp, Dept Med Educ, Linkou Main Branch, Taoyuan, Taiwan
[2] Chang Gung Univ, Coll Med, Sch Med, Taoyuan, Taiwan
[3] Chang Gung Mem Hosp, Dept Dermatol, Linkou Main Branch, Taoyuan, Taiwan
[4] Chang Gung Mem Hosp, Dept Dermatol, Linkou Main Branch, 5 Fuxing St, Taoyuan 333423, Taiwan
关键词
Evidence pyramid; evidence-based dermatology; evidence-based medicine; level of evidence; study design; LUNG-CANCER; SMOKING; MORTALITY; ASSOCIATION; ENVIRONMENT; EFFICACY; MEDICINE; DISEASE;
D O I
10.4103/ds.DS-D-23-00159
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
Levels of evidence (LOE), also known as hierarchies of evidence, are determined primarily by the inherent bias and validity of the study designs. Understanding LOE is a crucial preliminary step in practicing evidence-based medicine (EBM) or evidence-based dermatology. These hierarchies facilitate the efficient acquisition of the best available evidence for clinicians in decision-making, as well as guiding researchers in conducting new studies with appropriate designs while considering the next higher LOE necessary to improve the quality of currently available evidence. This article provides a concise overview of LOE and study designs based on the 2011 Oxford Centre for Evidence-Based Medicine LOE for treatment benefits. We utilize examples from medical literature to elucidate the strengths and limitations of various study designs. Furthermore, we shed light on the key concepts of the updated evidence pyramid and how the EBM research roadmap functions to bridge the gap between current best evidence and clinical practice.
引用
收藏
页码:199 / 205
页数:7
相关论文
共 29 条
[21]   The n-of-1 clinical trial: the ultimate strategy for individualizing medicine? [J].
Lillie, Elizabeth O. ;
Patay, Bradley ;
Diamant, Joel ;
Issell, Brian ;
Topol, Eric J. ;
Schork, Nicholas J. .
PERSONALIZED MEDICINE, 2011, 8 (02) :161-173
[22]  
MCBRIDE WG, 1961, LANCET, V2, P1358
[23]  
Murad M Hassan, 2016, Evid Based Med, V21, P125, DOI 10.1136/ebmed-2016-110401
[24]  
Pacovsky J, 2011, Rozhl Chir, V90, P478
[25]   Ivermectin for preventing and treating COVID-19 [J].
Popp, Maria ;
Reis, Stefanie ;
Schiesser, Selina ;
Hausinger, Renate Ilona ;
Stegemann, Miriam ;
Metzendorf, Maria-Inti ;
Kranke, Peter ;
Meybohm, Patrick ;
Skoetz, Nicole ;
Weibel, Stephanie .
COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2022, (06)
[26]   Evidence based medicine: What it is and what it isn't - It's about integrating individual clinical expertise and the best external evidence [J].
Sackett, DL ;
Rosenberg, WMC ;
Gray, JAM ;
Haynes, RB ;
Richardson, WS .
BRITISH MEDICAL JOURNAL, 1996, 312 (7023) :71-72
[27]   Using Grading of Recommendations Assessment, Development, and Evaluation (GRADE) to rate the certainty of evidence of study outcomes from systematic reviews: A quick tutorial [J].
Shao, Shih-Chieh ;
Kuo, Liang-Tseng ;
Huang, Yen-Ta ;
Lai, Pei-Chun ;
Chi, Ching-Chi .
DERMATOLOGICA SINICA, 2023, 41 (01) :3-7
[28]   N-of-1 Randomized Trials to Assess the Efficacy of Gabapentin for Chronic Neuropathic Pain [J].
Yelland, Michael J. ;
Poulos, Christopher J. ;
Pillans, Peter I. ;
Bashford, Guy M. ;
Nikles, Catherine Jane ;
Sturtevant, Joanna M. ;
Vine, Norma ;
Del Mar, Christopher B. ;
Schluter, Philip J. ;
Tan, Meng ;
Chan, Jonathan ;
Mackenzie, Fraser ;
Brown, Robyn .
PAIN MEDICINE, 2009, 10 (04) :754-761
[29]   Hazard Ratio of Smoking on Lung Cancer in Korea According to Histological Type and Gender [J].
Yun, Young Duk ;
Back, Joung Hwan ;
Ghang, Haryeom ;
Jee, Sun Ha ;
Kim, Yeol ;
Lee, Sun Mi ;
Samet, Jonathan M. ;
Lee, Kang Soo .
LUNG, 2016, 194 (02) :281-289